🌎 30+ NEW AI-picked share strategies for exciting international marketsUnlock Global AI Picks

Colgate-Palmolive executive sells over $2.2 million in stock

Published 12/08/2024, 21:22

CL
0.74%

In a recent move, Colgate-Palmolive Co's (NYSE:CL) Chief Legal Officer and Secretary, Jennifer Daniels, sold a significant number of shares in the company. According to the latest filings, Daniels parted with 22,000 shares of common stock, fetching a total of over $2.2 million. The transactions occurred on August 8, 2024, and were priced at a weighted average of $102.76 per share, with individual sales ranging from $102.58 to $102.98.

This sale came on the same day Daniels exercised options to acquire the same number of shares under the company's incentive compensation plan. The options were exercised at a price of $72.29 per share, amounting to a total of approximately $1.59 million. Following these transactions, Daniels' direct ownership in Colgate-Palmolive has decreased to 59,726 shares of common stock.

The transactions were part of a planned strategy involving the exercise of stock options awarded under the issuer's incentive compensation plan. A portion of the proceeds from the sale of shares was used to cover the exercise price of the options and the related tax withholding.

Investors often monitor insider transactions such as these for insights into executives' perspectives on their company's stock value. While such sales and acquisitions can be part of standard financial planning and diversification strategies, they can also reflect the executives' confidence in the company's current valuation and future prospects.

Colgate-Palmolive, a household name in personal care, continues to be a staple in investment portfolios, with its stock performance and corporate decisions closely watched by market participants.

In other recent news, Colgate-Palmolive Company (NYSE:CL) experienced robust growth in the second quarter of 2024, with a return to mid single-digit volume growth and expanding gross margins. This success was driven by innovation, strategic marketing, and the use of data analytics and AI tools. TD Cowen has increased its price target on Colgate-Palmolive Company to $115, maintaining a Buy rating. The firm also revised its earnings per share growth estimate for the company upward to 11.1% from 10.5%, anticipating higher costs. Jefferies, while maintaining a Hold rating, increased the shares target of Colgate to $101 from $95, expressing caution about the sustainability of such performance.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.

Evercore ISI maintained an Outperform rating and raised the price target from $106 to $112, highlighting Colgate's strong growth prospects and high return on invested capital within the household and personal care industry. The company reported favorable volume growth in various markets, particularly in Brazil and Mexico. Despite potential industry deceleration in Europe, Colgate-Palmolive maintained solid volume growth and plans to continue this trajectory with a consistent pricing and promotional strategy. These are among the recent developments for the multinational consumer products company.

InvestingPro Insights

As Colgate-Palmolive Co's (NYSE:CL) Chief Legal Officer and Secretary, Jennifer Daniels, engages in significant stock transactions, investors are examining the company's financial health and market performance for deeper insights. An analysis of Colgate-Palmolive's real-time data from InvestingPro shows a robust financial position. The company boasts an impressive gross profit margin of 59.7%, indicating strong operational efficiency in generating profits from its sales over the last twelve months as of Q2 2024.

Additionally, Colgate-Palmolive's commitment to shareholder returns is evident, as the company has raised its dividend for 34 consecutive years, with a current dividend yield of 1.96%. This consistent increase in dividends underscores the company's financial stability and dedication to returning value to its shareholders. The dividend growth rate over the last twelve months as of Q2 2024 stands at 4.17%.

InvestingPro Tips highlight that Colgate-Palmolive is trading at a low P/E ratio relative to near-term earnings growth, which currently stands at 29.35. This could suggest that the stock is undervalued considering its earnings potential. Furthermore, the company's stock is known to trade with low price volatility, offering a more stable investment option in the personal care sector.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.

For investors seeking additional insights, there are over 10 more InvestingPro Tips available for Colgate-Palmolive at https://www.investing.com/pro/CL, which can provide further guidance on the company's performance and investment potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Should you invest $2,000 in CL right now?

Before you buy stock in CL, consider this: ProPicks AI are 6 easy-to-follow model portfolios created by Investing.com for building wealth by identifying winning stocks and letting them run. Over 150,000 paying members trust ProPicks to find new stocks to buy – driven by AI. The ProPicks AI algorithm has just identified the best stocks for investors to buy now. The stocks that made the cut could produce enormous returns in the coming years. Is CL one of them?

Reveal Undervalued Stocks Now

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.